APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Proteins and Peptides

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Proteins and Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025187 pages

Choose your research edition.

Industry ResearchOral Proteins and Peptides Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Proteins and Peptides Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Oral Proteins and Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Proteins and Peptides Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Proteins and Peptides Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Oral Proteins and Peptides market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oral Proteins and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Proteins and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Proteins and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Proteins and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Proteins and Peptides include Ironwood & Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, Novartis and Chiasma (Amryt Pharma), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Proteins and Peptides market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Proteins and Peptides and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Proteins and Peptides sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Proteins and Peptides market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Proteins and Peptides Segment by Company

Ironwood & Allergan

Novo Nordisk

Synergy Pharmaceuticals （Salix）

Novartis

Chiasma (Amryt Pharma)

Oral Proteins and Peptides Segment by Type

Linaclotide

Insulin

Plecanatide

Cyclosporine

Octreotide

Oral Proteins and Peptides Segment by Application

Gastric & Digestive Disorders

Bone Diseases

Diabetes

Hormonal Disorders

Oral Proteins and Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Proteins and Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Proteins and Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Proteins and Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Proteins and Peptides market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Proteins and Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral Proteins and Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral Proteins and Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral Proteins and Peptides Industry Trends Table 2. Oral Proteins and Peptides Industry Drivers Table 3. Oral Proteins and Peptides Industry Opportunities and Challenges Table 4. Oral Proteins and Peptides Industry Restraints Table 5. Global Oral Proteins and Peptides Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral Proteins and Peptides Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral Proteins and Peptides Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Oral Proteins and Peptides Sales Market Share by Manufacturers Table 9. Global Oral Proteins and Peptides Average Sales Price (US$/mg) of Manufacturers (2021-2026) Table 10. Global Oral Proteins and Peptides Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral Proteins and Peptides Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral Proteins and Peptides Manufacturers, Product Type & Application Table 13. Global Oral Proteins and Peptides Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Proteins and Peptides by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Linaclotide Table 17. Major Manufacturers of Insulin Table 18. Major Manufacturers of Plecanatide Table 19. Major Manufacturers of Cyclosporine Table 20. Major Manufacturers of Octreotide Table 21. Global Oral Proteins and Peptides Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 22. Global Oral Proteins and Peptides Sales by Type (2021-2026) & (Kg) Table 23. Global Oral Proteins and Peptides Sales by Type (2027-2032) & (Kg) Table 24. Global Oral Proteins and Peptides Sales Market Share by Type (2021-2026) Table 25. Global Oral Proteins and Peptides Sales Market Share by Type (2027-2032) Table 26. Global Oral Proteins and Peptides Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 27. Global Oral Proteins and Peptides Revenue by Type (2021-2026) & (Kg) Table 28. Global Oral Proteins and Peptides Revenue by Type (2027-2032) & (Kg) Table 29. Global Oral Proteins and Peptides Revenue Market Share by Type (2021-2026) Table 30. Global Oral Proteins and Peptides Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Gastric & Digestive Disorders Table 32. Major Manufacturers of Bone Diseases Table 33. Major Manufacturers of Diabetes Table 34. Major Manufacturers of Hormonal Disorders Table 35. Global Oral Proteins and Peptides Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 36. Global Oral Proteins and Peptides Sales by Application (2021-2026) & (Kg) Table 37. Global Oral Proteins and Peptides Sales by Application (2027-2032) & (Kg) Table 38. Global Oral Proteins and Peptides Sales Market Share by Application (2021-2026) Table 39. Global Oral Proteins and Peptides Sales Market Share by Application (2027-2032) Table 40. Global Oral Proteins and Peptides Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 41. Global Oral Proteins and Peptides Revenue by Application (2021-2026) & (Kg) Table 42. Global Oral Proteins and Peptides Revenue by Application (2027-2032) & (Kg) Table 43. Global Oral Proteins and Peptides Revenue Market Share by Application (2021-2026) Table 44. Global Oral Proteins and Peptides Revenue Market Share by Application (2027-2032) Table 45. Global Oral Proteins and Peptides Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 46. Global Oral Proteins and Peptides Sales by Region (2021-2026) & (Kg) Table 47. Global Oral Proteins and Peptides Sales Market Share by Region (2021-2026) Table 48. Global Oral Proteins and Peptides Sales Forecasted by Region (2027-2032) & (Kg) Table 49. Global Oral Proteins and Peptides Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Oral Proteins and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 51. North America Oral Proteins and Peptides Sales by Country (2021-2026) & (Kg) Table 52. North America Oral Proteins and Peptides Sales by Country (2027-2032) & (Kg) Table 53. Europe Oral Proteins and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 54. Europe Oral Proteins and Peptides Sales by Country (2021-2026) & (Kg) Table 55. Europe Oral Proteins and Peptides Sales by Country (2027-2032) & (Kg) Table 56. Asia Pacific Oral Proteins and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 57. Asia Pacific Oral Proteins and Peptides Sales by Country (2021-2026) & (Kg) Table 58. Asia Pacific Oral Proteins and Peptides Sales by Country (2027-2032) & (Kg) Table 59. South America, Middle East and Africa Oral Proteins and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 60. South America, Middle East and Africa Oral Proteins and Peptides Sales by Country (2021-2026) & (Kg) Table 61. South America, Middle East and Africa Oral Proteins and Peptides Sales by Country (2027-2032) & (Kg) Table 62. Global Oral Proteins and Peptides Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Oral Proteins and Peptides Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Oral Proteins and Peptides Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Oral Proteins and Peptides Revenue Market Share by Region (2021-2026) Table 66. Global Oral Proteins and Peptides Revenue Market Share by Region (2027-2032) Table 67. Ironwood & Allergan Company Information Table 68. Ironwood & Allergan Business Overview Table 69. Ironwood & Allergan Oral Proteins and Peptides Sales (Kg), Price (US$/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Ironwood & Allergan Oral Proteins and Peptides Product Portfolio Table 71. Ironwood & Allergan Recent Development Table 72. Novo Nordisk Company Information Table 73. Novo Nordisk Business Overview Table 74. Novo Nordisk Oral Proteins and Peptides Sales (Kg), Price (US$/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Novo Nordisk Oral Proteins and Peptides Product Portfolio Table 76. Novo Nordisk Recent Development Table 77. Synergy Pharmaceuticals （Salix） Company Information Table 78. Synergy Pharmaceuticals （Salix） Business Overview Table 79. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales (Kg), Price (US$/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product Portfolio Table 81. Synergy Pharmaceuticals （Salix） Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Oral Proteins and Peptides Sales (Kg), Price (US$/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Novartis Oral Proteins and Peptides Product Portfolio Table 86. Novartis Recent Development Table 87. Chiasma (Amryt Pharma) Company Information Table 88. Chiasma (Amryt Pharma) Business Overview Table 89. Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales (Kg), Price (US$/mg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolio Table 91. Chiasma (Amryt Pharma) Recent Development Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. Oral Proteins and Peptides Distributors List Table 95. Oral Proteins and Peptides Customers List Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Oral Proteins and Peptides Product Image Figure 2. Global Oral Proteins and Peptides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Proteins and Peptides Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Proteins and Peptides Sales (2021-2032) & (Kg) Figure 5. Global Oral Proteins and Peptides Average Price (US$/mg) & (2021-2032) Figure 6. Global Top 5 and 10 Oral Proteins and Peptides Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Linaclotide Image Figure 9. Insulin Image Figure 10. Plecanatide Image Figure 11. Cyclosporine Image Figure 12. Octreotide Image Figure 13. Global Oral Proteins and Peptides Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Oral Proteins and Peptides Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Oral Proteins and Peptides Sales Market Share by Type (2021-2032) Figure 16. Global Oral Proteins and Peptides Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 17. Global Oral Proteins and Peptides Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Oral Proteins and Peptides Revenue Market Share by Type (2021-2032) Figure 19. Gastric & Digestive Disorders Image Figure 20. Bone Diseases Image Figure 21. Diabetes Image Figure 22. Hormonal Disorders Image Figure 23. Global Oral Proteins and Peptides Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global Oral Proteins and Peptides Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Oral Proteins and Peptides Sales Market Share by Application (2021-2032) Figure 26. Global Oral Proteins and Peptides Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 27. Global Oral Proteins and Peptides Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Oral Proteins and Peptides Revenue Market Share by Application (2021-2032) Figure 29. North America Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 30. North America Oral Proteins and Peptides Sales Market Share by Country (2021-2032) Figure 31. U.S. Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Canada Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 33. Mexico Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 34. Europe Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 35. Europe Oral Proteins and Peptides Sales Market Share by Country (2021-2032) Figure 36. Germany Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 37. France Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 38. U.K. Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Italy Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 40. Netherlands Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Asia Pacific Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 42. Asia Pacific Oral Proteins and Peptides Sales Market Share by Country (2021-2032) Figure 43. China Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 44. Japan Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 45. South Korea Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 46. Southeast Asia Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 47. India Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 48. Australia Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South America, Middle East and Africa Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 50. South America, Middle East and Africa Oral Proteins and Peptides Sales Market Share by Country (2021-2032) Figure 51. Brazil Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 52. South Africa Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 53. Saudi Arabia Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Turkey Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Argentina Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 56. UAE Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 57. Egypt Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 58. Chile Oral Proteins and Peptides Sales and Growth Rate (2021-2032) & (Kg) Figure 59. Global Oral Proteins and Peptides Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Oral Proteins and Peptides Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Oral Proteins and Peptides Revenue (2021-2032) & (US$ Million) Figure 62. North America Oral Proteins and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Oral Proteins and Peptides Revenue (2021-2032) & (US$ Million) Figure 64. Europe Oral Proteins and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Oral Proteins and Peptides Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Oral Proteins and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Oral Proteins and Peptides Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Oral Proteins and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Oral Proteins and Peptides Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Oral Proteins and Peptides Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Linaclotide
  • Insulin
  • Plecanatide
  • Cyclosporine
  • Octreotide
Applications
  • Gastric & Digestive Disorders
  • Bone Diseases
  • Diabetes
  • Hormonal Disorders
Companies covered
  • Ironwood & Allergan
  • Novo Nordisk
  • Synergy Pharmaceuticals （Salix）
  • Novartis
  • Chiasma (Amryt Pharma)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral Proteins and Peptides Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral Proteins and Peptides Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral Proteins and Peptides Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral Proteins and Peptides Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral Proteins and Peptides Market Dynamics
  1. 2.1 Oral Proteins and Peptides Industry Trends
  2. 2.2 Oral Proteins and Peptides Industry Drivers
  3. 2.3 Oral Proteins and Peptides Industry Opportunities and Challenges
  4. 2.4 Oral Proteins and Peptides Industry Restraints
3 Oral Proteins and Peptides Market by Manufacturers
  1. 3.1 Global Oral Proteins and Peptides Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral Proteins and Peptides Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral Proteins and Peptides Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral Proteins and Peptides Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Proteins and Peptides Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral Proteins and Peptides Manufacturers, Product Type & Application
  7. 3.7 Global Oral Proteins and Peptides Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Proteins and Peptides Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Proteins and Peptides Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Proteins and Peptides Tier 1, Tier 2, and Tier 3
4 Oral Proteins and Peptides Market by Type
  1. 4.1 Oral Proteins and Peptides Type Introduction
  2. 4.1.1 Linaclotide
  3. 4.1.2 Insulin
  4. 4.1.3 Plecanatide
  5. 4.1.4 Cyclosporine
  6. 4.1.5 Octreotide
  7. 4.2 Global Oral Proteins and Peptides Sales by Type
  8. 4.2.1 Global Oral Proteins and Peptides Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Oral Proteins and Peptides Sales by Type (2021-2032)
  10. 4.2.3 Global Oral Proteins and Peptides Sales Market Share by Type (2021-2032)
  11. 4.3 Global Oral Proteins and Peptides Revenue by Type
  12. 4.3.1 Global Oral Proteins and Peptides Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Oral Proteins and Peptides Revenue by Type (2021-2032)
  14. 4.3.3 Global Oral Proteins and Peptides Revenue Market Share by Type (2021-2032)
5 Oral Proteins and Peptides Market by Application
  1. 5.1 Oral Proteins and Peptides Application Introduction
  2. 5.1.1 Gastric & Digestive Disorders
  3. 5.1.2 Bone Diseases
  4. 5.1.3 Diabetes
  5. 5.1.4 Hormonal Disorders
  6. 5.2 Global Oral Proteins and Peptides Sales by Application
  7. 5.2.1 Global Oral Proteins and Peptides Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Oral Proteins and Peptides Sales by Application (2021-2032)
  9. 5.2.3 Global Oral Proteins and Peptides Sales Market Share by Application (2021-2032)
  10. 5.3 Global Oral Proteins and Peptides Revenue by Application
  11. 5.3.1 Global Oral Proteins and Peptides Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Oral Proteins and Peptides Revenue by Application (2021-2032)
  13. 5.3.3 Global Oral Proteins and Peptides Revenue Market Share by Application (2021-2032)
6 Global Oral Proteins and Peptides Sales by Region
  1. 6.1 Global Oral Proteins and Peptides Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Proteins and Peptides Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Proteins and Peptides Sales by Region (2021-2026)
  4. 6.2.2 Global Oral Proteins and Peptides Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral Proteins and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral Proteins and Peptides Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral Proteins and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral Proteins and Peptides Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral Proteins and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral Proteins and Peptides Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral Proteins and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral Proteins and Peptides Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral Proteins and Peptides Revenue by Region
  1. 7.1 Global Oral Proteins and Peptides Revenue by Region
  2. 7.1.1 Global Oral Proteins and Peptides Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral Proteins and Peptides Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral Proteins and Peptides Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral Proteins and Peptides Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral Proteins and Peptides Revenue (2021-2032)
  8. 7.2.2 North America Oral Proteins and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral Proteins and Peptides Revenue (2021-2032)
  11. 7.3.2 Europe Oral Proteins and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral Proteins and Peptides Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral Proteins and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral Proteins and Peptides Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral Proteins and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ironwood & Allergan
  2. 8.1.1 Ironwood & Allergan Company Information
  3. 8.1.2 Ironwood & Allergan Business Overview
  4. 8.1.3 Ironwood & Allergan Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ironwood & Allergan Oral Proteins and Peptides Product Portfolio
  6. 8.1.5 Ironwood & Allergan Recent Developments
  7. 8.2 Novo Nordisk
  8. 8.2.1 Novo Nordisk Company Information
  9. 8.2.2 Novo Nordisk Business Overview
  10. 8.2.3 Novo Nordisk Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novo Nordisk Oral Proteins and Peptides Product Portfolio
  12. 8.2.5 Novo Nordisk Recent Developments
  13. 8.3 Synergy Pharmaceuticals （Salix）
  14. 8.3.1 Synergy Pharmaceuticals （Salix） Company Information
  15. 8.3.2 Synergy Pharmaceuticals （Salix） Business Overview
  16. 8.3.3 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product Portfolio
  18. 8.3.5 Synergy Pharmaceuticals （Salix） Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Oral Proteins and Peptides Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Chiasma (Amryt Pharma)
  26. 8.5.1 Chiasma (Amryt Pharma) Company Information
  27. 8.5.2 Chiasma (Amryt Pharma) Business Overview
  28. 8.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolio
  30. 8.5.5 Chiasma (Amryt Pharma) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Proteins and Peptides Value Chain Analysis
  2. 9.1.1 Oral Proteins and Peptides Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Proteins and Peptides Production Mode & Process
  6. 9.2 Oral Proteins and Peptides Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Proteins and Peptides Distributors
  9. 9.2.3 Oral Proteins and Peptides Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst